Yuichi Yamasaki

Kagoshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Novel susceptible human leukocyte antigens allele in juvenile dermatomyositis: A study in Japanese patients.

Novel susceptible human leukocyte antigens allele in juvenile dermatomyositis: A study in Japanese patients.

Journal: Pediatrics and neonatology

Published: December 17, 2025

Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus.

Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus.

Journal: Modern rheumatology

Published: July 11, 2025

Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

Journal: Pediatric rheumatology online journal

Published: June 19, 2025

TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan.

TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan.

Journal: Pediatric rheumatology online journal

Published: May 16, 2025

Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations.

Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations.

Journal: Cytokine

Published: April 15, 2025

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial.

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial.

Journal: Arthritis care & research

Published: March 14, 2025

Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin-Associated Periodic Syndrome.

Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin-Associated Periodic Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 04, 2025

Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.

Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 04, 2023

Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis.

Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis.

Journal: Modern rheumatology

Published: August 22, 2022

Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.

Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.

Journal: Rheumatology (Oxford, England)

Published: December 16, 2020

Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages.

Anti-TNF treatment corrects IFN-γ-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages.

Journal: The Journal of allergy and clinical immunology

Published: November 11, 2020

A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.

A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.

Journal: Clinical rheumatology

Published: May 07, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026